A biokinetic model to describe the distribution and excretion of arsenic by man following acute and chronic intakes of arsenite/arsenate compounds by ingestion

Human and Experimental Toxicology

Volumn 29, Issue 11, 2010, Pages 891-902

  Adeyemi, A ^a   Garelick, H ^a   Priest, Nd ^a  

^a MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

arsenic; bioassay; metabolism; modelling

Indexed keywords

ARSENIC; ARSENIC ACID; RADIOISOTOPE;

ARTICLE; DIETARY INTAKE; DRUG TISSUE LEVEL; FECES; HUMAN; HUMAN TISSUE; INGESTION; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; POPULATION; PREDICTION; PRIORITY JOURNAL; UNITED STATES; URINARY EXCRETION;

ARSENATES; ARSENITES; ENVIRONMENTAL EXPOSURE; HUMANS; METABOLIC DETOXICATION, DRUG; MODELS, BIOLOGICAL; TISSUE DISTRIBUTION; WATER POLLUTANTS, CHEMICAL;

EID: 77958544413     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110364912     Document Type: Article

References (30)

1. Smedley PL, Kinniburgh DG A review of the source, behaviour and distribution of As in natural waters, Appl Geochem 2002 ; 17: 517-568.
2. Ipcs. International Programme on Chemical Safety, Environmental Health Criteria on As and As Compounds. Environmental Health Criteria Series 224. 2 nd Ed. WHO, Geneva, 2001.
3. Ishinishi N., Tsuchiya K., Vahter M., Fowler BA As In: Friberg L, Norberg GF, Vouk VB (eds.) Handbook on the Toxicology of Metals, Volume II., Amsterdam: Elsevier Science Publishers, 1986, pp. 43-83.
4. Iarc. As and As compounds. In: Some metals and metallic compounds. IARC Mono. Evaluation of the carcinogenic risks to humans, 1987 ; 23: 39-141.
5. Atsdr. Toxicological Profile for As. US Department of Health and Human Services, Atlanta: Agency for Toxic Substances and Disease Registry, 2000, pp. 1-468.
6. Icrp. International Commission on Radiological Protection, Publication 30, Part 3. Annals of the ICRP 1981 ; 6: 2 / 3.
7. El-Masri HA, Kenyon EM Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic As and its mono- and di-methylated metabolites. J Pharmacokinetics Pharmacodynamics 2008 ; 35: 31-68.
8. Wester RC, Maibach HI, Sedik L., Melendres J., Wade M. In vitro and in vivo percutaneous absorption and skin decontamination of As from water and soil. Fun-dam Appl Toxicol 1993 ; 20: 336-340.
9. Pomroy C., Charbonneau SM, McCullough RS, Tam GHK. Human retention studies of 74As. Toxicol Appl Pharmacol 1980 ; 53: 550-556.
10. Bhattacharyya R., Chatterjee D., Nath B., Jana J., Jacks G., Vahter M. High As groundwater: mobilisation, metabolism and mitigation - an overview in the Bengal Delta Plain. Mol Cellular Biochem 2003 ; 253: 347-355.
11. Ducoff HS, Neal WB, Straube RL, Jacobson LO, Brues AM Biologic studies with As76, II, excretion and tissue location. Proc Soc Exper Biol Med 1948 ; 69: 548-554.
12. Benedetti J-L. As (PIM G042) [www] IPCS Intox Databank. url: http://www.intox.org/databank/documents/chemical/As/pimg042.html ( 1996, accessed 7 December 2005).
13. Sneddon IR, Garelick H., Valsami-Jones E. An investigation into As(V) removal from aqueous solutions by hydroxylapatite and bone-char. Mineralogic Mag 2005 ; 69: 769-780.
14. Chen Y-C., Guo LL-Y, Su H-JJ, Hsueh Y-M., Smith TJ, Ryan LM, et al. As methylation and skin cancer risk in Southwestern Taiwan. J Occup Environ Med 2003 ; 45: 241-248.
15. Chen Y-C., Su H-JJ, Guo LL-Y, Hsueh Y-M., Smith TJ, Ryan LM, et al. As methylation and bladder cancer risk in Taiwan. Cancer Causes Contro 2003 ; 14: 303-310.
16. Liebscher K., Smith H. Essential and nonessential trace elements. A method of determining an element is essential or nonessential in human tissue. Arch Environ Health 1968 ; 17: 881-890.
17. Kadowaki K. Studies on the As contents in organ-tissues of the normal Japanese. Osaka City Med J 1960 ; 9: 2083-2099 (in Japanese with English summary).
18. Icrp. International Commission on Radiological Protection, Publication 23: Report of task group on reference man. Oxford UK: Pergamon Press, 1975 ; pp. 225-227.
19. Priest ND, Birchall A. Sensitivity testing of an age-related multicompartment dosimetric model of bone-surface seeking radionuclides in man, Appendix. Health Phys 1989 ; 57: 229-242.
20. Icrp. International Commission on Radiological Protection, Publication 78. Annals of the ICRP 1997 ; 27: 3 / 4.
21. Lin SM, Chiang CH, Yang MH As concentration in the urine of patients with Blackfoot disease and Bowenĝ€™s disease. Biol Trace Element Res 1986 ; 8: 11-18.
22. Ruiz-Navarro ML, Navarro-Alar‡on M., Lopez G., de la Serrana H., PeÅ•ez-Valero V., López-Martinez MC Urine As concentrations in healthy adults as indicators of environmental contamination; relation with some pathologies. Sci Total Environ 1998 ; 216: 55-61.
23. Jain CK, Ali I. As: occurrence, toxicity and speciation techniques. Water Res 2000 ; 34: 4304-4312.
24. Akter FK, Owens G., Davey DE, Naidu R. As speciation and toxicity in biological systems. Rev Environ Contamin Toxicol 2005 ; 184: 97-149.
25. NAS. As in drinking water. Washington DC: National Academy Press, 1999, pp. 83-192.
26. Hansen HR, Raab A., Francesconi KA, Feldmann J. Metabolism of As in sheep chronically exposed to arsenosugars as a normal part of their diet: (1) Quantitative intake, uptake and excretion. Environ Sci Technol 2003 ; 37: 845-851.
27. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD Levels of urinary total and speciated As in the US population: National Health Nutrition Examination Survey 2003-2004. J Expos Sci Environ Epidemiol 2009 ; 19, 59-68.
28. Benramdane L., Accominotti M., Fanton L., Malicier D., Vallon JJ As speciation in human organs following fatal As trioxide Poisoning - a case report. Clin Chem 1999 ; 45: 301-306.
29. Saady JJ, Blanke RV, Poklis A. Estimation of the body burden of As in a child fatally poisoned by arsenite weedkiller. J Anal Toxicol 1989 ; 13: 310-312.
30. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, et al. Urinary trivalent methylated As species in a population chronically exposed to inorganic As. Environ Health Perspect 2005 ; 113: 250-254.